☰

Kinga Szigeti - Publications

Affiliations: 
Neurology State University of New York, Buffalo, Buffalo, NY, United States 
Tree Info Grants Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Szigeti K, Ihnatovych I, Birkaya B, Chen Z, Ouf A, Indurthi DC, Bard JE, Kann J, Adams A, Chaves L, Sule N, Reisch JS, Pavlik V, Benedict RHB, Auerbach A, et al. CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease. Ebiomedicine. 59: 102892. PMID 32818803 DOI: 10.1016/J.Ebiom.2020.102892  0.31
2019 Ihnatovych I, Nayak TK, Ouf A, Sule N, Birkaya B, Chaves L, Auerbach A, Szigeti K. iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context. Translational Psychiatry. 9: 59. PMID 30710073 DOI: 10.1038/S41398-019-0375-Z  0.301
2019 Szigeti K, Chen Z, Ouf A, Reisch J, Pavlik V, Wilding G. P4‐675: Cholinesterase Inhibitors Have A Disease Modifying Effect In Ad Relative To Chrfam7A Genotype, Suggesting An A7Nachr Dependent Mechanism Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.09.041  0.338
2018 Lew AR, Kellermayer TR, Sule BP, Szigeti K. Copy Number Variations in Adult-onset Neuropsychiatric Diseases. Current Genomics. 19: 420-430. PMID 30258274 DOI: 10.2174/1389202919666180330153842  0.397
2018 Woodward MR, Hafeez MU, Qi Q, Riaz A, Benedict RHB, Yan L, Szigeti K. Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 29858162 DOI: 10.1016/J.Jagp.2018.02.008  0.333
2017 Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH, Szigeti K. Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease. Psychiatry Research. 266: 90-95. PMID 28644998 DOI: 10.1016/J.Pscychresns.2017.06.004  0.348
2017 Hafeez MU, Mun KT, Kamal H, Szigeti K. Delusional Misidentification Syndrome with Response to Donepezil and Behavioral Intervention in a Patient with Dementia Journal of Aging Science. 5: 1-6. DOI: 10.4172/2329-8847.1000181  0.327
2017 Ouf A, Szigeti K. Evidence-Based Review of Therapeutic Approaches in Dementia with Lewy Bodies Journal of Alzheimers Disease & Parkinsonism. 7: 1-5. DOI: 10.4172/2161-0460.1000406  0.333
2016 Roy S, Ficarro S, Duberstein P, Chapman BP, Dubovsky S, Paroski M, Szigeti K, Benedict RH. Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27618644 DOI: 10.1016/J.Jagp.2016.06.014  0.304
2016 Szigeti K. New Genome-Wide Methods for Elucidation of Candidate Copy Number Variations (CNVs) Contributing to Alzheimer's Disease Heritability. Methods in Molecular Biology (Clifton, N.J.). 1303: 315-26. PMID 26235076 DOI: 10.1007/978-1-4939-2627-5_19  0.386
2016 Woodward MR, Hafeez MU, Khan MU, Hagemeier J, Yan L, Qi Q, Szigeti K. Characterization of Olfactory Identification Deficit in Aging Vs. Alzheimer's Disease American Journal of Geriatric Psychiatry. 24. DOI: 10.1016/J.Jagp.2016.01.099  0.34
2015 Szigeti K, Hafeez MU. Exploring the role of donepezil in dementia with Lewy bodies. Drugs of Today. 51: 579-590. PMID 26583300 DOI: 10.1358/Dot.2015.51.10.2389166  0.322
2015 Woodward MR, Dwyer MG, Amrutkar CV, Zivadinov R, Szigeti K. Olfactory Identification Deficit as a Predictor of White Matter Tract Integrity in Alzheimer's Disease American Journal of Geriatric Psychiatry. 23. DOI: 10.1016/J.Jagp.2014.12.104  0.323
2014 Szigeti K, Kellermayer B, Lentini JM, Trummer B, Lal D, Doody RS, Yan L, Liu S, Ma C. Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease Journal of Alzheimer's Disease. 41: 1063-1071. PMID 24787912 DOI: 10.3233/Jad-132693  0.398
2013 Jensen M, Cox AP, Chaudhry N, Ng M, Sule D, Duncan W, Ray P, Weinstock-Guttman B, Smith B, Ruttenberg A, Szigeti K, Diehl AD. The neurological disease ontology. Journal of Biomedical Semantics. 4: 42. PMID 24314207 DOI: 10.1186/2041-1480-4-42  0.331
2013 Szigeti K, Lal D, Li Y, Doody RS, Wilhelmsen K, Yan L, Liu S, Ma C. Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 517-23. PMID 23202439 DOI: 10.3233/Jad-2012-121285  0.402
2013 Szigeti K, Trummer B, Lal D, Yan L, Song L, Doody R. Ordered subset analysis CNV association with Alzheimer's disease AAO phenotypes Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.287  0.374
2012 Li Y, Shaw CA, Sheffer I, Sule N, Powell SZ, Dawson B, Zaidi SN, Bucasas KL, Lupski JR, Wilhelmsen KC, Doody R, Szigeti K. Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease. Translational Psychiatry. 2: e192. PMID 23168992 DOI: 10.1038/Tp.2012.119  0.338
2012 Szigeti K, Li Y, Shaw C, Sheffer I, Sule N, Powell S, Zaidi N, Lupski J, Wilhelmsen K, Doody R. Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease Alzheimers & Dementia. 8: 672. DOI: 10.1016/J.Jalz.2012.05.1817  0.396
2011 Szigeti K, Doody RS. Should persons with autosomal dominant AD be included in clinical trials? Authors' response. Alzheimer's Research & Therapy. 3: 19. PMID 21631907 DOI: 10.1186/Alzrt81  0.35
2011 Shaw CA, Li Y, Wiszniewska J, Chasse S, Zaidi SN, Jin W, Dawson B, Wilhelmsen K, Lupski JR, Belmont JW, Doody RS, Szigeti K. Olfactory copy number association with age at onset of Alzheimer disease. Neurology. 76: 1302-9. PMID 21482944 DOI: 10.1212/Wnl.0B013E3182166Df5  0.4
2011 Szigeti K, Doody RS. Should EOAD patients be included in clinical trials? Alzheimer's Research & Therapy. 3: 4. PMID 21345175 DOI: 10.1186/Alzrt63  0.358
2010 Antonellis A, Dennis MY, Burzynski G, Huynh J, Maduro V, Hodonsky CJ, Khajavi M, Szigeti K, Mukkamala S, Bessling SL, Pavan WJ, McCallion AS, Lupski JR, Green ED. A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo. Plos One. 5: e14346. PMID 21179557 DOI: 10.1371/Journal.Pone.0014346  0.343
2010 McLaughlin HM, Sakaguchi R, Liu C, Igarashi T, Pehlivan D, Chu K, Iyer R, Cruz P, Cherukuri PF, Hansen NF, Mullikin JC, Biesecker LG, Wilson TE, Ionasescu V, ... ... Szigeti K, et al. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. American Journal of Human Genetics. 87: 560-6. PMID 20920668 DOI: 10.1016/J.Ajhg.2010.09.008  0.394
2009 England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF, et al. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Pm & R : the Journal of Injury, Function, and Rehabilitation. 1: 5-13. PMID 19627867 DOI: 10.1016/J.Pmrj.2008.11.010  0.307
2009 Szigeti K, Lupski JR. Charcot-Marie-Tooth disease. European Journal of Human Genetics : Ejhg. 17: 703-10. PMID 19277060 DOI: 10.1038/Ejhg.2009.31  0.406
2009 England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, et al. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle & Nerve. 39: 116-25. PMID 19086068 DOI: 10.1002/Mus.21226  0.316
2009 England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 72: 185-92. PMID 19056666 DOI: 10.1212/01.Wnl.0000336370.51010.A1  0.307
2009 Szigeti K, Shaw C, Li Y, Lupski JR, Belmont J, Doody RS. Olfactory receptor cluster copy number is associated with age at onset of Alzheimer's disease Alzheimers & Dementia. 5: 469. DOI: 10.1016/J.Jalz.2009.04.795  0.315
2007 Szigeti K, Wiszniewski W, Saifi GM, Sherman DL, Sule N, Adesina AM, Mancias P, Papasozomenos SCh, Miller G, Keppen L, Daentl D, Brophy PJ, Lupski JR. Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations. Neurogenetics. 8: 257-62. PMID 17717711 DOI: 10.1007/S10048-007-0094-0  0.334
2006 Szigeti K, Nelis E, Lupski JR. Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies. Neuromolecular Medicine. 8: 243-54. PMID 16775379 DOI: 10.1385/Nmm:8:1-2:243  0.317
2006 Verhoeven K, Claeys KG, Züchner S, Schröder JM, Weis J, Ceuterick C, Jordanova A, Nelis E, De Vriendt E, Van Hul M, Seeman P, Mazanec R, Saifi GM, Szigeti K, Mancias P, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain : a Journal of Neurology. 129: 2093-102. PMID 16714318 DOI: 10.1093/Brain/Awl126  0.336
2006 Szigeti K, Garcia CA, Lupski JR. Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 8: 86-92. PMID 16481890 DOI: 10.1097/01.Gim.0000200160.29385.73  0.37
2006 Shy ME, Scavina MT, Clark A, Krajewski KM, Li J, Kamholz J, Kolodny E, Szigeti K, Fischer RA, Saifi GM, Scherer SS, Lupski JR. T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy. Annals of Neurology. 59: 358-64. PMID 16437560 DOI: 10.1002/Ana.20777  0.343
2005 Saifi GM, Szigeti K, Wiszniewski W, Shy ME, Krajewski K, Hausmanowa-Petrusewicz I, Kochanski A, Reeser S, Mancias P, Butler I, Lupski JR. SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Human Mutation. 25: 372-83. PMID 15776429 DOI: 10.1002/Humu.20153  0.357
2003 Saifi GM, Szigeti K, Snipes GJ, Garcia CA, Lupski JR. Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 51: 261-83. PMID 14577517 DOI: 10.1136/Jim-51-05-14  0.35
2003 Szigeti K, Saifi GM, Armstrong D, Belmont JW, Miller G, Lupski JR. Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. Annals of Neurology. 54: 398-402. PMID 12953275 DOI: 10.1002/Ana.10681  0.317
Show low-probability matches.